{"id":"https://openalex.org/W2591156492","doi":"https://doi.org/10.1200/jco.2014.32.3_suppl.636","title":"Clinical benefits of bevacizumab in metastatic colorectal cancer depending on KRAS status.","display_name":"Clinical benefits of bevacizumab in metastatic colorectal cancer depending on KRAS status.","publication_year":2014,"publication_date":"2014-01-20","ids":{"openalex":"https://openalex.org/W2591156492","doi":"https://doi.org/10.1200/jco.2014.32.3_suppl.636","mag":"2591156492"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2014.32.3_suppl.636","doi":"https://doi.org/10.1200/jco.2014.32.3_suppl.636","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.3_suppl.636","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086955860","display_name":"Keisuke Kurimoto","orcid":"https://orcid.org/0009-0001-5036-8554","observed_orcids":["https://orcid.org/0009-0001-5036-8554"]},"institutions":[{"id":"https://openalex.org/I4210086899","display_name":"Konan Kosei Hospital","ror":"https://ror.org/00178zy73","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210086899"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Keisuke Kurimoto","raw_affiliation_strings":["Konan Kosei Hospital, Konan, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Konan Kosei Hospital, Konan, Japan","institution_ids":["https://openalex.org/I4210086899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021947929","display_name":"Kiyoshi Ishigure","orcid":"https://orcid.org/0000-0003-3687-9021","observed_orcids":["https://orcid.org/0000-0003-3687-9021"]},"institutions":[{"id":"https://openalex.org/I4210086899","display_name":"Konan Kosei Hospital","ror":"https://ror.org/00178zy73","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210086899"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kiyoshi Ishigure","raw_affiliation_strings":["Konan Kosei Hospital, Konan, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Konan Kosei Hospital, Konan, Japan","institution_ids":["https://openalex.org/I4210086899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060906966","display_name":"Yoshiyasu Kato","orcid":"https://orcid.org/0000-0002-2203-256X","observed_orcids":["https://orcid.org/0000-0002-2203-256X"]},"institutions":[{"id":"https://openalex.org/I4210086899","display_name":"Konan Kosei Hospital","ror":"https://ror.org/00178zy73","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210086899"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshiyasu Kato","raw_affiliation_strings":["Konan Kosei Hospital, Konan, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Konan Kosei Hospital, Konan, Japan","institution_ids":["https://openalex.org/I4210086899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028597074","display_name":"Yasuyuki Asai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086899","display_name":"Konan Kosei Hospital","ror":"https://ror.org/00178zy73","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210086899"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yasuyuki Asai","raw_affiliation_strings":["Konan Kosei Hospital, Konan, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Konan Kosei Hospital, Konan, Japan","institution_ids":["https://openalex.org/I4210086899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035016570","display_name":"Nobutake Tanaka","orcid":"https://orcid.org/0000-0002-2519-1494","observed_orcids":["https://orcid.org/0000-0002-2519-1494"]},"institutions":[{"id":"https://openalex.org/I4210086899","display_name":"Konan Kosei Hospital","ror":"https://ror.org/00178zy73","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210086899"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Nobutake Tanaka","raw_affiliation_strings":["Konan Kosei Hospital, Konan, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Konan Kosei Hospital, Konan, Japan","institution_ids":["https://openalex.org/I4210086899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037439876","display_name":"Song Ryo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086899","display_name":"Konan Kosei Hospital","ror":"https://ror.org/00178zy73","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210086899"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Song Ryo","raw_affiliation_strings":["Konan Kosei Hosipital, Konan, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Konan Kosei Hosipital, Konan, Japan","institution_ids":["https://openalex.org/I4210086899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004757198","display_name":"Hidenobu Matsushita","orcid":"https://orcid.org/0000-0002-8520-5966","observed_orcids":["https://orcid.org/0000-0002-8520-5966"]},"institutions":[{"id":"https://openalex.org/I4210086899","display_name":"Konan Kosei Hospital","ror":"https://ror.org/00178zy73","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210086899"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hidenobu Matsushita","raw_affiliation_strings":["Konan Kosei Hosipital, Konan, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Konan Kosei Hosipital, Konan, Japan","institution_ids":["https://openalex.org/I4210086899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026822663","display_name":"Junichi Tobinaga","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086899","display_name":"Konan Kosei Hospital","ror":"https://ror.org/00178zy73","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210086899"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Junichi Tobinaga","raw_affiliation_strings":["Konan Kosei Hosipital, Konan, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Konan Kosei Hosipital, Konan, Japan","institution_ids":["https://openalex.org/I4210086899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113735027","display_name":"Ryuichi Fukuyama","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086899","display_name":"Konan Kosei Hospital","ror":"https://ror.org/00178zy73","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210086899"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Ryuichi Fukuyama","raw_affiliation_strings":["Konan Kosei Hosipital, Konan, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Konan Kosei Hosipital, Konan, Japan","institution_ids":["https://openalex.org/I4210086899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068635103","display_name":"Hiruhumi Kuroda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086899","display_name":"Konan Kosei Hospital","ror":"https://ror.org/00178zy73","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210086899"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiruhumi Kuroda","raw_affiliation_strings":["Konan Kosei Hosipital, Konan, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Konan Kosei Hosipital, Konan, Japan","institution_ids":["https://openalex.org/I4210086899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112242966","display_name":"Tomoo Fujii","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086899","display_name":"Konan Kosei Hospital","ror":"https://ror.org/00178zy73","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I4210086899"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomoo Fujii","raw_affiliation_strings":["Konan Kosei Hosipital, Konan, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Konan Kosei Hosipital, Konan, Japan","institution_ids":["https://openalex.org/I4210086899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210086899"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"32","issue":"3_suppl","first_page":"636","last_page":"636"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10335","display_name":"Colorectal Cancer Surgical Treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bevacizumab","display_name":"bevacizumab","score":0.9919999837875366},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.9919999837875366},{"id":"https://openalex.org/keywords/kras-mutation-status","display_name":"KRAS mutation status","score":0.8799999952316284},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.9010000228881836},{"id":"https://openalex.org/keywords/oxaliplatin-based-chemotherapy","display_name":"oxaliplatin-based chemotherapy","score":0.902999997138977},{"id":"https://openalex.org/keywords/irinotecan-based-chemotherapy","display_name":"irinotecan-based chemotherapy","score":0.9520000219345093},{"id":"https://openalex.org/keywords/first-line-treatment","display_name":"first-line therapy","score":0.7960000038146973},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9470000267028809},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9399999976158142},{"id":"https://openalex.org/keywords/tumor-response-rate","display_name":"tumor response rate","score":0.5180000066757202},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7329999804496765},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.6230000257492065},{"id":"https://openalex.org/keywords/treatment-benefit-stratification","display_name":"treatment benefit stratification","score":0.44999998807907104}],"concepts":[{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.9447124600410461},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9281610250473022},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.9028984904289246},{"id":"https://openalex.org/C2780259306","wikidata":"https://www.wikidata.org/wiki/Q412197","display_name":"Irinotecan","level":4,"score":0.7864782810211182},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.7300670146942139},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7157564759254456},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.61094069480896},{"id":"https://openalex.org/C2780962732","wikidata":"https://www.wikidata.org/wiki/Q422327","display_name":"Oxaliplatin","level":4,"score":0.5643455982208252},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.42526745796203613},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.34121906757354736},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.31903398036956787},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.31579554080963135}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2014.32.3_suppl.636","doi":"https://doi.org/10.1200/jco.2014.32.3_suppl.636","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2014.32.3_suppl.636","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9763000011444092,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2034020560","https://openalex.org/W2590570006","https://openalex.org/W2054122365","https://openalex.org/W2171790106","https://openalex.org/W2080651866","https://openalex.org/W2589242464","https://openalex.org/W2081238655","https://openalex.org/W2525371782","https://openalex.org/W2765952344","https://openalex.org/W2008009461"],"abstract_inverted_index":{"636":[0],"Background:":[1],"KRAS":[2,35,50,102,133,157,185,228,234,243,255,312,321],"status":[3,134],"is":[4,24,272],"the":[5,14,40,93,109,242,246,254],"therapeutic":[6],"marker":[7,16],"of":[8,17,43,108,135,143,303,320],"anti-EGFR":[9],"drug,":[10],"and":[11,92,125,141,161,232,315],"may":[12],"be":[13],"prognostic":[15],"metastatic":[18],"colorectal":[19],"cancer":[20],"(mCRC).":[21],"However,":[22],"there":[23,271,282],"no":[25,151,204,220,273,284],"consensus":[26],"whether":[27],"bevacizumab":[28,44,62,124,323],"(anti-VEGF":[29],"drug)":[30],"benefits":[31,42,326],"patients":[32,57,110,119,127,137,145,183,193,257,328],"with":[33,61,123,131,184,194,329],"mutated":[34],"in":[36,46,153,212,227,233,253],"mCRC.":[37,330],"We":[38,54,74],"investigated":[39,55],"clinical":[41,325],"treatment":[45,65],"mCRC":[47,67],"depending":[48,100],"on":[49,101],"status,":[51,322],"retrospectively.":[52],"Methods:":[53],"49":[56,167],"who":[58],"received":[59,120,128],"chemotherapies":[60,122,130],"as":[63],"first-line":[64],"for":[66,327],"from":[68],"May":[69],"2008":[70],"through":[71],"June":[72],"2013.":[73],"evaluated":[75],"response":[76],"rate":[77,81,91,226],"(RR),":[78],"disease":[79],"control":[80],"(DCR),":[82],"progression-free":[83],"survival":[84,87],"(PFS),":[85],"overall":[86],"(OS),":[88],"tumor":[89],"reduction":[90,225],"adverse":[94,305],"events":[95,306],"(CTCAE":[96],"v4.0":[97],"-":[98,116],"JCOG)":[99],"status.":[103],"Results:":[104],"The":[105,175,223,301],"median":[106,176,247,280],"age":[107],"was":[111,138,146,150,170,173,178,210,230,236,249,283,307],"66":[112],"years":[113],"(range;":[114],"36":[115],"80).":[117],"Forty-five":[118],"oxaliplatin-based":[121],"four":[126],"irinotecan-based":[129],"bevacizumab.":[132],"30":[136],"wild":[139,158,186,244],"type":[140,159,163,187,196],"that":[142,252],"19":[144],"mutation":[147,162],"type.":[148],"There":[149],"difference":[152,275,285],"patient":[154],"characteristics":[155],"between":[156,276,286,311],"(WT)":[160],"(MT).":[164],"In":[165,181,241,279],"all":[166],"patients,":[168,245],"RR":[169],"62.5%.":[171],"DCR":[172,213],"91.7%.":[174],"PFS":[177,248],"10.9":[179],"months.":[180],"RR,":[182],"tumors":[188,197],"had":[189],"better":[190],"outcome":[191],"than":[192,251],"mutant":[195,256],"(WT":[198,214,258,289],":":[199,202,215,218,259,262,290,293],"MT,":[200,216,260,291],"69.0%":[201],"52.6%,":[203],"statistically":[205,221,274,309],"difference).":[206,222],"A":[207],"similar":[208],"tendency":[209],"seen":[211],"96.6%":[217],"84.2%,":[219],"average":[224],"WT":[229,313],"42.7%":[231],"MT":[235,316],"32.3%":[237],"(p":[238],"=":[239,268,299],"0.309).":[240],"longer":[250],"11.8":[261],"8.9":[263],"months,":[264,295],"Log":[265,296],"Rank":[266,297],"p":[267,298],"0.583),":[269],"but":[270],"two":[277,287],"groups.":[278],"OS,":[281],"groups":[288],"21.0":[292],"20.8":[294],"0.393).":[300],"incidence":[302],"severe":[304],"not":[308],"different":[310],"group":[314],"group.":[317],"Conclusions:":[318],"Regardless":[319],"provides":[324]},"counts_by_year":[{"year":2016,"cited_by_count":1}],"updated_date":"2026-09-21T07:43:02.447757","created_date":"2017-03-03T00:00:00"}